1Hospital for Special Surgery, Cornell University Medical Center, New York, NY 10021, USA.
Systemic lupus erythematosus (SLE) patients do not show specific defects in Fas ligand (FasL) function. T cell cytotoxicity reductions in SLE patients are comparable to rheumatoid arthritis patients, suggesting subtle activation differences.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: